Safety and Food Effect on Single-Dose Bioavailability of F-02-2-Na in Healthy Adult Subjects

NCT07346027 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperuricemia With or Without Gout

Interventions

DRUG: Fasting administration of F-02-2-Na (50mg) - Fed administration of F-02-2-Na (50mg)
DRUG: Fed administration of F-02-2-Na (50mg) - Fasting administration of F-02-2-Na (50mg)

Sponsor

Guangdong Hengqin Novagains Biopharmaceutical Co., Ltd.

Collaborators

[object Object]
[object Object]